The FDA Voted to Allow Compounding of Peptides. Topical. Oral. Safe Track Record. Far Better Than mRNA or DNA Genetic Technologies. Peptides used topically — in cosmetics, in skin regeneration, in oral buccal applications — have a strong and well-documented safety profile. The FDA panel's vote to allow compounding opens new avenues of treatment that don't carry the risks of synthetic mRNA or DNA plasmid technologies. Oral and topical peptide administration currently falls under FTC jurisdiction — and that's where it should stay. This is medicine moving in the right direction: effective, accessible, and not built on untested genetic platforms. Join the Fight: Courtesy of Real America's Voice @RealAmVoice, American Sunrise, Dr. Gina Loudon @RealDrGina #MedicalFreedom#